BioHarvest Sciences, Inc. (BHST)
2.02
-0.03
(-1.46%)
USD |
NASDAQ |
Aug 25, 12:54
BioHarvest Sciences EPS Diluted (Quarterly) : -0.1639 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1639 |
| March 31, 2026 | -0.1165 |
| December 31, 2025 | -0.10 |
| September 30, 2025 | -0.1442 |
| June 30, 2025 | -0.2354 |
| March 31, 2025 | -0.1349 |
| December 31, 2024 | -0.1706 |
| September 30, 2024 | -0.1551 |
| June 30, 2024 | -0.042 |
| March 31, 2024 | -0.4788 |
| December 31, 2023 | -0.5288 |
| September 30, 2023 | -0.1288 |
| June 30, 2023 | -0.2125 |
| March 31, 2023 | -0.0564 |
| December 31, 2022 | -0.2167 |
| September 30, 2022 | -0.30 |
| June 30, 2022 | -0.1831 |
| March 31, 2022 | -0.1642 |
| December 31, 2021 | -0.1351 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.2453 |
| June 30, 2021 | 0.1442 |
| March 31, 2021 | -0.5635 |
| December 31, 2020 | -0.2639 |
| September 30, 2020 | -0.1536 |
| June 30, 2020 | -0.1319 |
| March 31, 2020 | -0.092 |
| January 31, 2019 | -0.4219 |
| October 31, 2018 | -2.421 |
| July 31, 2018 | -0.0349 |
| April 30, 2018 | -0.0887 |
| January 31, 2018 | -0.0437 |
| October 31, 2017 | -0.0899 |
| July 31, 2017 | -0.0684 |
| April 30, 2017 | -0.0821 |
| January 31, 2017 | -0.042 |
| October 31, 2016 | -0.0649 |
| July 31, 2016 | -0.0562 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cyanotech Corp. | 0.0396 |
| Mannatech, Inc. | 0.5259 |
| Natural Alternatives International, Inc. | -0.7155 |
| USANA Health Sciences, Inc. | -1.157 |
| Nature's Sunshine Products, Inc. | 0.1929 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.715M |
| Revenue (Quarterly) | 8.837M |
| Total Expenses (Quarterly) | 12.55M |
| Enterprise Value | 47.80M |
| Gross Profit Margin (Quarterly) | 57.51% |
| Profit Margin (Quarterly) | -42.04% |
| Earnings Yield | -25.97% |
| Normalized Earnings Yield | -25.97 |